Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s share price traded up 2.3% on Friday . The company traded as high as €47.00 ($48.45) and last traded at €46.56 ($48.00). Approximately 224,325 ...

Key Insights The projected fair value for Carl Zeiss Meditec is €77.77 based on 2 Stage Free Cash Flow to Equity ...

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices, or OPT, and microsurgery, or MCS. OPT makes up roughly 75% ...

In a report released on December 22, Oliver Reinberg from Kepler Capital maintained a Hold rating on Carl Zeiss Meditec (0DHC – Research ...

There's been a notable change in appetite for Carl Zeiss Meditec AG (ETR ... This is an important time for investors, as they can track a company's performance in its report, look at what experts ...

Narrow-moat Carl Zeiss Meditec reported soft fourth-quarter earnings that came in lower than our expectations and ended the year on a soft note. Total sales of EUR 580 million during the quarter ...

Investing.com -- Shares of Carl Zeiss Meditec AG fell by 7% on Wednesday after the company reported mixed full-year results for FY2023/24 and issued guidance for FY2024/25 that fell short of ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...